Vault-13

IMMURON LTD IMRN

SPONSORED ADR · ADR · CUSIP 45254U101

Small biotech company

6 institutional holders
128,292128.3k shares reported held*
$466.0kreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.63.

Insider purchases and sales in Q4 2019

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q4 2019.

Holders, Q4 2019

#ManagerLocationShares Value% of their portfolioChangeShares change
1 COURAGE CAPITAL MANAGEMENT LLC 1.18% of their portfolio NASHVILLE, TN 107,101107.1k $389.0k $389.0k 1.18% —
2 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 10,13210.1k $37.0k $37.0k 0.00% —
3 DEUTSCHE BANK AG\ 0.00% of their portfolio FRANKFURT AM MAIN, 2M 7,7907.8k $28.0k $28.0k 0.00% —
4 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 2,2692.3k $8.0k $8.0k 0.00% —
5 LADENBURG THALMANN FINANCIAL SERVICES INC. 0.00% of their portfolio MIAMI, FL 1,0001.0k $4.0k $4.0k 0.00% —
6 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% —